Education & Research at NYU Langone Health | NYU Langone Health

Skip to Main Content

NYU Grossman School of Medicine

We're challenging conventions to drive innovation in science and medicine.

Education & Research at NYU Langone Health

We’re pushing the boundaries in medical education and research to benefit the lives of our patients. Learn more about our vibrant research community in the heart of New York City.

Research

We bring together the brightest minds in biomedical research to solve healthcare’s biggest questions.

Education

We’re committed to training physicians and scientists at every career stage. Explore our educational programs.

By the Numbers
220

laboratories devoted to biomedical research

#2

medical school in the nation for research, according to U.S. News’ 2022 “Best Graduate Schools”

53

countries represented in our labs

News

NYU Grossman School of Medicine Is Making Changes to Encourage Diversity in Orthopedic Surgery

Read More
Read more: NYU Grossman School of Medicine Is Making Changes to Encourage Diversity in Orthopedic Surgery
News

How We Delivered More Than 156,000 Doses of COVID-19 Vaccine in 5 Months

Read More
Read more: How We Delivered More Than 156,000 Doses of COVID-19 Vaccine in 5 Months
News

Dr. Akuezunkpa O. Ude Welcome Named Chief of Surgery at NYU Langone Hospital—Brooklyn

Read More
Read more: Dr. Akuezunkpa O. Ude Welcome Named Chief of Surgery at NYU Langone Hospital—Brooklyn
News

Study Confirms Nutrient’s Role in Childhood Blood Cancer

Read More
Read more: Study Confirms Nutrient’s Role in Childhood Blood Cancer
News

Experimental Compound Counters Diabetic Complications

Read More
Read more: Experimental Compound Counters Diabetic Complications
News

Perlmutter Cancer Center Ranks as Top New York City Clinical Trials Program for Gynecologic Cancers

Read More
Read more: Perlmutter Cancer Center Ranks as Top New York City Clinical Trials Program for Gynecologic Cancers
News

Anti-Platelet Drug Class Does Not Increase Survival in Hospitalized COVID-19 Patients with Moderate Cases

Read More
Read more: Anti-Platelet Drug Class Does Not Increase Survival in Hospitalized COVID-19 Patients with Moderate Cases